Vivo Capital’s Precision BioSciences DTIL Stock Holding History

Vivo Capital’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.7K	Hold	4,675	–	–	﹤0.01%	46
2025 Q4	$19.4K	Hold	4,675	–	–	﹤0.01%	47
2025 Q3	$25.8K	Hold	4,675	–	–	﹤0.01%	47
2025 Q2	$19.6K	Hold	4,675	–	–	﹤0.01%	42
2025 Q1	$22.3K	Hold	4,675	–	–	﹤0.01%	40
2024 Q4	$17.8K	Hold	4,675	–	–	﹤0.01%	40
2024 Q3	$41.9K	Hold	4,675	–	–	﹤0.01%	43
2024 Q2	$45.5K	Hold	4,675	–	–	﹤0.01%	42
2024 Q1	$63.4K	Hold	4,675	–	–	0.01%	42
2023 Q4	$51.2K	Hold	4,675	–	–	﹤0.01%	47
2023 Q3	$47.9K	Hold	4,675	–	–	0.01%	53
2023 Q2	$73.8K	Hold	4,675	–	–	0.01%	48
2023 Q1	$106K	Hold	4,675	–	–	0.01%	48
2022 Q4	$167K	Hold	4,675	–	–	0.02%	48
2022 Q3	$182K	Hold	4,675	–	–	0.02%	50
2022 Q2	$224K	Hold	4,675	–	–	0.02%	48
2022 Q1	$432K	Hold	4,675	–	–	0.03%	52
2021 Q4	$1.04M	Hold	4,675	–	–	0.06%	53
2021 Q3	$1.62M	Hold	4,675	–	–	0.07%	57
2021 Q2	$1.76M	Hold	4,675	–	–	0.08%	57
2021 Q1	$1.45M	Hold	4,675	–	–	0.05%	61
2020 Q4	$1.17M	Hold	4,675	–	–	0.05%	57
2020 Q3	$864K	Hold	4,675	–	–	0.05%	64
2020 Q2	$1.17M	Hold	4,675	–	–	0.08%	54
2020 Q1	$846K	Buy	+4,675	New	+$1.22M	0.08%	53
2019 Q3	–	Sell	-9,350	Closed	-$3.72M	–	15
2019 Q2	$3.72M	Hold	9,350	–	–	0.35%	37
2019 Q1	$5.04M	Buy	+9,350	New	+$4.96M	0.5%	37

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vivo Capital's DTIL Position: Q1 2026 in Review

Vivo Capital held its Precision BioSciences (DTIL) position steady in Q1 2026 at 4,675 shares worth $25.7K. The position accounts for ﹤0.01% of the portfolio, ranked #46.

Vivo Capital first reported a position in DTIL in Q1 2019 and has held it in 27 quarters since. The position peaked at $5.04M in Q1 2019. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Vivo Capital held 4,675 shares of Precision BioSciences worth $25.7K as of Q1 2026.
Vivo Capital left its Precision BioSciences share count unchanged in Q1 2026.
Precision BioSciences made up ﹤0.01% of Vivo Capital's portfolio in Q1 2026, its #46 holding.
Vivo Capital first reported a position in Precision BioSciences in Q1 2019 and has held it in 27 quarters since.
Vivo Capital's Precision BioSciences position peaked at $5.04M in Q1 2019.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Vivo Capital's 13F filing for Q1 2026, filed 15 May 2026.